Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arria NLG is a commercial enterprise software company focused on natural language generation and broader generative AI applications for turning structured data into automated narratives and decision support. Its core offering, the Arria Language Platform, includes products such as Arria Studio, Arria Author, and Arria Answers for data-to-text automation, reporting, and conversational analytics. The company serves multiple industries including financial services, government, energy, and pharma/life sciences, where its tools are used for applications such as business intelligence, clinical safety reporting, regulatory reporting, and trial management narratives. Although it markets solutions into pharmaceutical and life sciences workflows, Arria is not itself a biotech, pharma, or healthcare therapeutics company. It appears to be an active private company with headquarters in Morristown, New Jersey and an international office footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arria NLG.